Erratum: Routine HIV testing in Botswana: A population-based study on attitudes, practices, and human rights concerns (PLoS Medicine 3,7, DOI: 10.1371/journal.pmed.0030261);Routine HIV testing in Botswana: A population-based study on attitudes, practices, and human rights concerns

PLoS Medicine

Volumn 3, Issue 7, 2006, Pages 1013-1022

  Weiser, Sheri D ^a,b,c   Heisler, Michele ^a,d   Leiter, Karen ^a   Percy De Korte, Fiona ^a   Tlou, Sheila ^e   DeMonner, Sonya ^a   Phaladze, Nthabiseng ^e   Bangsberg, David R ^c   Iacopino, Vincent ^a,f  

^a PHYSICIANS FOR HUMAN RIGHTS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF BOTSWANA   (Botswana)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BOTSWANA; CONTROLLED STUDY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; MEDICAL EXAMINATION; PREVALENCE; PUBLIC OPINION; SCREENING; SEXUAL BEHAVIOR; VIOLENCE; WOMEN'S RIGHTS; ADULT; ATTITUDE TO HEALTH; CONFIDENTIALITY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; FEAR; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; REFUSAL TO PARTICIPATE; RISK; SAFE SEX; SERODIAGNOSIS; SOCIAL PSYCHOLOGY; STATISTICS; VOLUNTARY PROGRAM;

ADULT; AIDS SERODIAGNOSIS; ATTITUDE TO HEALTH; BOTSWANA; CONFIDENTIALITY; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TESTS, ROUTINE; FEAR; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HIV INFECTIONS; HIV SEROPREVALENCE; HUMAN RIGHTS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PREJUDICE; REFUSAL TO PARTICIPATE; RISK; SAFE SEX; SEXUAL BEHAVIOR; VIOLENCE; VOLUNTARY PROGRAMS;

EID: 33746419189     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030395     Document Type: Erratum

References (56)

1. WHO (2003) Leading the health sector response to HIV/AIDS. Geneva: World Health Organization.
2. Global HIV Prevention Working Group (2003) Access to HIV prevention: Closing the gap. Bill and Melinda Gates Foundation and Henry J. Kaiser Foundation.
3. Sweat M, Gregorich S, Sangiwa G, et al. (2000) Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 356: 113-121.
4. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group (2000) Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: A randomised trial. Lancet 356: 103-112.
5. Global HIV Prevention Working Group (2004) HIV prevention in the era of expanded treatment access. Bill and Melinda Gates Foundation.
6. Kalichman SC, Simbayi LC (2003) HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sex Transm Infect Dis 79: 442-447.
7. (2003) Botswana 2003 second generation HIV/AIDS surveillance. Gaborone: The National AIDS Coordinating Agency.
8. (2003) Botswana national strategic framework for HIV/AIDS 2003-2009. Gaborone: National AIDS Coordinating Agency.
9. (2004) Rolling out ARV therapy in Botswana. Gaborone: MASA, Botswana Ministry of Health.
10. (2004) Botswana MASA antiretroviral therapy programme monthly report. Gaborone: MASA, Botswana Ministry of Health.
11. (2004) Botswana's strategy to combat HIV/AIDS: Lessons for Africa and President Bush's emergency plan for AIDS relief. Washington: The Center for Strategic and International Studies.
12. de Korte D, Mazonde P, Darkoh E (2004) Introducing ARV therapy in the public sector in Botswana: Case study. Geneva: World Health Organization.
13. (2004) The ideal versus the best: AIDS testing. Economist 370: 76.
14. Wolfe WR, Weiser SD, Bangsberg DR, et al. (2006) Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care. In press.
15. Kenyon K (2005) Routine HIV testing: A view from Botswana. Health Hum Rights 8: 21-23.
16. De Cock KM (2005) HIV testing in the era of treatment scale-up. Health Hum Rights 8: 31-35.
17. Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 352: 570-585.
18. Walensky RP, Weinstein MC, Kimmel AD, et al. (2005) Routine human immunodeficiency virus testing: An economic evaluation of current guidelines. Am J Med 118: 292-300.
19. Paltiel AD, Weinstein MC, Kimmel AD, et al. (20050 Expanded screening for HIV in the United States - An analysis of cost-effectiveness. N Engl J Med 352: 586-595.
20. Kelen GD, Shahan JB, Quinn TC (1999) Emergency department-based HIV screening and counseling: Experience with rapid and standard serologic testing. Ann Emerg Med 33: 147-155.
21. (2001) Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 50: 1-57; quiz CE51-19a51-CE56-19a51.
22. UNAIDS Global Reference Group on HIV/AIDS and Human Rights. (2004) UNAIDS/WHO policy statement on HIV testing.
23. Heywood MJ (2005) . Heywood MJ (2005) The routine offer of HIV counseling and testing: A human right. 8: 13-19.
24. (2004) Consultative meeting on HIV Testing and counseling in the Africa region; 17 November 2004. Johannesburg: Joint United Nations Programme on HIV/AIDS.
25. Csete J, Schleifer R, Cohen J (2004) "Opt-out" testing for HIV in Africa: A caution. Lancet 363: 493-494.
26. (2005) The international community of women living with HIV/AIDS: Point of view. Health Hum Rights 8: 25-26.
27. Gruskin S, Tarantola D, Maluwa M, Ahmed S (2004) National HIV testing policies: Human rights considerations. Proceedings of the XVth International AIDS Conference; 11-16 July 2004; Bangkok, Thailand.
28. Wang FL, Larke B, Gabos S, Hanrahan A, Schopflocher D (2005) Potential factors that may affect acceptance of routine prenatal HIV testing. Can J Public Health 96: 60-64.
29. De Cock KM, Marum E, Mbori-Ngacha D (2003) A serostatus-based approach to HIV/AIDS prevention and care in Africa. Lancet 362: 1847-1849.
30. De Cock KM, Mbori-Ngacha D, Marum E (2002) Shadow on the continent: Public health and HIV/AIDS in Africa in the 21st century. Lancet 360: 67-72.
31. Day JH, Miyamura K, Grant AD, et al. (2003) Attitudes to HIV voluntary counselling and testing among mineworkers in South Africa: Will availability of antiretroviral therapy encourage testing? AIDS Care 15: 665-672.
32. Warwick Z (2004) The influence of antiretroviral treatment on the uptake of HIV testing in Botswana. Proceedings of the XVth International AIDS Conference;11-16 July 2004; Bangkok, Thailand.
33. Maman S, Mbwambo J, Hogan NM, Kilonzo GP, Sweat M (2001) Women's barriers to HIV-1 testing and disclosure: Challenges for HIV-1 voluntary counselling and testing. AIDS Care 13: 595-603.
34. Matovu JK, Gray RH, Makumbi F, et al. (2005) Voluntary HIV counseling and testing acceptance, sexual risk behavior and HIV incidence in Rakai, Uganda. AIDS 19: 503-511.
35. Bond L, Lauby J, Batson H (2005) HIV testing and the role of individualand structural-level barriers and facilitators. AIDS Care 17: 125-140.
36. Fylkesnes K, Siziya S (2004) A randomized trial on acceptability of voluntary HIV counselling and testing. Trop Med Int Health 9: 566-572.
37. Chesney M, Smith AW (1999) Critical delays in HIV testing and care: The potential role of stigma. Am Behav Scientist 42: 1158-1170.
38. Letamo G (2003) Prevalence of, and factors associated with, HIV/AIDSrelated stigma and discriminatory attitudes in Botswana. J Health Popul Nutr 21: 347-357.
39. Cook JA, Cohen MH, Burke J, et al. (2002) Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr 30: 401-409.
40. Ickovics JR, Hamburger ME, Vlahov D, et al. (2001) Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA 285: 1466-1474.
41. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL (2003) Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 114: 573-580.
42. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L (1974). The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry 7: 79-110.
43. Bolton P, Wilk CM, Ndogoni L (2004) Assessment of depression prevalence in rural Uganda using symptom and function criteria. Soc Psychiatry Psychiatr Epidemiol 39: 442-447.
44. (2004) Introduction of routine HIV testing in prenatal care - Botswana, 2004. MMWR Morb Mortal Wkly Rep 53: 1083-1086.
45. WHO (2005) Summary of country profile for HIV/AIDS treatment scaleup. Geneva: World Health Organization.
46. Kamb ML, Fishbein M, Douglas JM Jr, et al. (1998) Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. JAMA 280:: 1161-1167. Project RESPECT Study Group.
47. Gruskin S (2005) Round table on scaling up HIV testing: Introduction. Health Hum Rights 8: 9-11.
48. Stall R, Hoff C, Coates TJ, et al. (1996) Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: Implications for secondary prevention efforts. J Acquir Immune Defic Syndr Hum Retrovirol 11: 151-160.
49. Herek GM, Capitanio JP, Widaman KF (2003) Stigma, social risk, and health policy: Public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychol 22: 533-540.
50. Molapo M, Molefe N, Hurkchand H, Makuluma H, Segobye A (2004) Behavioral KAP survey of women migrants living in the surrounding communties of coal, gold and diamond mining complexes in South Africa and Botswana. Proceedings of the XVth International AIDS Conference; 11-16 July 2004; Bangkok, Thailand.
51. Parker R, Aggleton P (2003) HIV and AIDS-related stigma and discrimination: A conceptual framework and implications for action. Soc Sci Med 57: 13-24.
52. Zimbabwe Central Statistical Office (2000) Zimbabwe demographic and health survey 1999. Calverton (Maryland): Macro International.
53. Shinsasa O, Simbayi L (2002) Nelson Mandela/HSRC study of HIV/AIDS: South African national HIV prevalence, behavioral risks and mass media, household survey 2002. Cape Town: HSRC Press.
54. (2003) Botswana AIDS Impact Survey, 2001. Gaborone: Central Statistics Office.
55. Gruskin S (2004) Current issues and concerns in HIV testing: A health and human rights approach. HIV/AIDS Pol Law Rev 9: 1-8.
56. Gostin L, Mann JM (1994) Towards the development of a human rights impact assessment for the formulation and evaluation of public health policies. Health Hum Rights 1: 58-80.